

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 9.97059803 |
| 2 | regulation of guanylate cyclase activity (GO:0031282) | 7.74647680 |
| 3 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.64210602 |
| 4 | NADH metabolic process (GO:0006734) | 7.23770704 |
| 5 | intestinal absorption (GO:0050892) | 6.71162581 |
| 6 | lipoprotein transport (GO:0042953) | 6.54697022 |
| 7 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.91339584 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 5.83724915 |
| 9 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.70345944 |
| 10 | regulation of bile acid biosynthetic process (GO:0070857) | 5.70075996 |
| 11 | fructose metabolic process (GO:0006000) | 5.63609463 |
| 12 | urea cycle (GO:0000050) | 5.50799901 |
| 13 | urea metabolic process (GO:0019627) | 5.17568204 |
| 14 | regulation of cellular extravasation (GO:0002691) | 5.15877022 |
| 15 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.98731891 |
| 16 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.87586132 |
| 17 | endocrine process (GO:0050886) | 4.87586132 |
| 18 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.87586132 |
| 19 | antibacterial humoral response (GO:0019731) | 4.80952109 |
| 20 | hormone catabolic process (GO:0042447) | 4.80080519 |
| 21 | diacylglycerol metabolic process (GO:0046339) | 4.79814021 |
| 22 | regulation of cGMP biosynthetic process (GO:0030826) | 4.77220578 |
| 23 | nitrogen cycle metabolic process (GO:0071941) | 4.74284358 |
| 24 | antimicrobial humoral response (GO:0019730) | 4.68081903 |
| 25 | homocysteine metabolic process (GO:0050667) | 4.64020983 |
| 26 | positive regulation of pseudopodium assembly (GO:0031274) | 4.61649454 |
| 27 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.53964795 |
| 28 | drug metabolic process (GO:0017144) | 4.48378085 |
| 29 | plasma lipoprotein particle assembly (GO:0034377) | 4.46842753 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 4.46239869 |
| 31 | regulation of systemic arterial blood pressure (GO:0003073) | 4.45349668 |
| 32 | cellular glucuronidation (GO:0052695) | 4.37643579 |
| 33 | glucuronate metabolic process (GO:0019585) | 4.36130410 |
| 34 | uronic acid metabolic process (GO:0006063) | 4.36130410 |
| 35 | bile acid and bile salt transport (GO:0015721) | 4.34800696 |
| 36 | vitamin A metabolic process (GO:0006776) | 4.31520786 |
| 37 | adhesion of symbiont to host cell (GO:0044650) | 4.25367658 |
| 38 | virion attachment to host cell (GO:0019062) | 4.25367658 |
| 39 | midgut development (GO:0007494) | 4.23770602 |
| 40 | digestion (GO:0007586) | 4.16098988 |
| 41 | regulation of vitamin metabolic process (GO:0030656) | 4.13184858 |
| 42 | regulation of pseudopodium assembly (GO:0031272) | 4.12149280 |
| 43 | peptide hormone processing (GO:0016486) | 4.07824054 |
| 44 | protein-lipid complex assembly (GO:0065005) | 4.06524094 |
| 45 | renal system process involved in regulation of blood volume (GO:0001977) | 4.02242083 |
| 46 | regulation of cGMP metabolic process (GO:0030823) | 4.00187340 |
| 47 | flavonoid metabolic process (GO:0009812) | 3.98753437 |
| 48 | glycolipid catabolic process (GO:0019377) | 3.94997797 |
| 49 | glycosphingolipid catabolic process (GO:0046479) | 3.93049447 |
| 50 | peptide catabolic process (GO:0043171) | 3.87848266 |
| 51 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.85601852 |
| 52 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.81512032 |
| 53 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.79631423 |
| 54 | phospholipid efflux (GO:0033700) | 3.77136354 |
| 55 | lipoprotein metabolic process (GO:0042157) | 3.72126337 |
| 56 | vitamin transmembrane transport (GO:0035461) | 3.71729829 |
| 57 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.71713420 |
| 58 | adhesion of symbiont to host (GO:0044406) | 3.69803948 |
| 59 | cGMP-mediated signaling (GO:0019934) | 3.63738359 |
| 60 | cellular response to nitric oxide (GO:0071732) | 3.62127492 |
| 61 | vitamin transport (GO:0051180) | 3.58029666 |
| 62 | arginine metabolic process (GO:0006525) | 3.57526600 |
| 63 | regulation of cholesterol esterification (GO:0010872) | 3.57106644 |
| 64 | citrulline biosynthetic process (GO:0019240) | 3.55373307 |
| 65 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.48675236 |
| 66 | positive regulation of respiratory burst (GO:0060267) | 3.47749522 |
| 67 | alkaloid metabolic process (GO:0009820) | 3.43218860 |
| 68 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.42012882 |
| 69 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.40067765 |
| 70 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.37818929 |
| 71 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.37818929 |
| 72 | cyclooxygenase pathway (GO:0019371) | 3.36003494 |
| 73 | fat-soluble vitamin metabolic process (GO:0006775) | 3.33920074 |
| 74 | response to nitric oxide (GO:0071731) | 3.30191065 |
| 75 | GDP-mannose metabolic process (GO:0019673) | 3.26722825 |
| 76 | eosinophil chemotaxis (GO:0048245) | 3.26012417 |
| 77 | positive regulation of lipid catabolic process (GO:0050996) | 3.23072535 |
| 78 | digestive system process (GO:0022600) | 3.21124862 |
| 79 | drinking behavior (GO:0042756) | 3.20927283 |
| 80 | glomerular filtration (GO:0003094) | 3.20316096 |
| 81 | transcytosis (GO:0045056) | 3.16758284 |
| 82 | citrulline metabolic process (GO:0000052) | 3.16674742 |
| 83 | bile acid metabolic process (GO:0008206) | 3.14921106 |
| 84 | glycosylceramide metabolic process (GO:0006677) | 3.13592245 |
| 85 | ceramide catabolic process (GO:0046514) | 3.11746649 |
| 86 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.11208712 |
| 87 | glycoside metabolic process (GO:0016137) | 3.08760336 |
| 88 | positive regulation of cGMP metabolic process (GO:0030825) | 3.07604861 |
| 89 | cobalamin metabolic process (GO:0009235) | 3.07409526 |
| 90 | drug catabolic process (GO:0042737) | 3.07314725 |
| 91 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.06371782 |
| 92 | drug transport (GO:0015893) | 3.05049588 |
| 93 | high-density lipoprotein particle remodeling (GO:0034375) | 3.04947553 |
| 94 | cellular response to reactive nitrogen species (GO:1902170) | 3.04814973 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 3.02351153 |
| 96 | mRNA modification (GO:0016556) | 3.01558621 |
| 97 | plasma lipoprotein particle organization (GO:0071827) | 2.99887682 |
| 98 | glycerol metabolic process (GO:0006071) | 2.98406042 |
| 99 | renal filtration (GO:0097205) | 2.98184538 |
| 100 | macromolecular complex remodeling (GO:0034367) | 2.97994226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.25666785 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.64806059 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.70703214 |
| 4 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.60795443 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.53334630 |
| 6 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.07982524 |
| 7 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.98884331 |
| 8 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.82739837 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.76865409 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.71527830 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.53928857 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.49068594 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.40484045 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.38327623 |
| 15 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.35320059 |
| 16 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.30158146 |
| 17 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.26490348 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.25757531 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.24901491 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.18612847 |
| 21 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.07694589 |
| 22 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.04552936 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.96415537 |
| 24 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.88406916 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86546678 |
| 26 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.83795025 |
| 27 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.83451372 |
| 28 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.82240927 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.80862365 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70123494 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.68523525 |
| 32 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.67826985 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64488405 |
| 34 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.64366951 |
| 35 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.62505924 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.61696237 |
| 37 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.57728491 |
| 38 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.55956351 |
| 39 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55422606 |
| 40 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.51553073 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51174324 |
| 42 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.47472753 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.42883674 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41583508 |
| 45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38706445 |
| 46 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.37156459 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36448544 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34827275 |
| 49 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31760670 |
| 50 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31402178 |
| 51 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.30769483 |
| 52 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.29279506 |
| 53 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.29234772 |
| 54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28284936 |
| 55 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.27837236 |
| 56 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.23088749 |
| 57 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20330747 |
| 58 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.19840049 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18736176 |
| 60 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.18212283 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17926498 |
| 62 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17080183 |
| 63 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.14275411 |
| 64 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.10550327 |
| 65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10263503 |
| 66 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.09965364 |
| 67 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.09932952 |
| 68 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07820944 |
| 69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07100614 |
| 70 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.07091055 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06070545 |
| 72 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.05992692 |
| 73 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.01732123 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01279139 |
| 75 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01198418 |
| 76 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01066629 |
| 77 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.00580191 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99853164 |
| 79 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.99027118 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97943896 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97179090 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96847341 |
| 83 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94234856 |
| 84 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.94041653 |
| 85 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93091332 |
| 86 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92179549 |
| 87 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91829452 |
| 88 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.90995528 |
| 89 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90902769 |
| 90 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90849172 |
| 91 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90530178 |
| 92 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90275229 |
| 93 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90048623 |
| 94 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.90035791 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88525776 |
| 96 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.87957463 |
| 97 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.84544873 |
| 98 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.84420099 |
| 99 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.83841914 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83609457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.64960665 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 4.68395879 |
| 3 | MP0001666_abnormal_nutrient_absorption | 4.62567183 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.21873521 |
| 5 | MP0009840_abnormal_foam_cell | 3.86359400 |
| 6 | MP0009379_abnormal_foot_pigmentation | 3.86095518 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.81400770 |
| 8 | MP0004019_abnormal_vitamin_homeostasis | 3.68869802 |
| 9 | MP0005365_abnormal_bile_salt | 3.28356953 |
| 10 | MP0004147_increased_porphyrin_level | 3.25881563 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 3.21312989 |
| 12 | MP0004264_abnormal_extraembryonic_tissu | 3.03986342 |
| 13 | MP0010155_abnormal_intestine_physiology | 2.91583936 |
| 14 | MP0000490_abnormal_crypts_of | 2.13340692 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.09855917 |
| 16 | MP0001664_abnormal_digestion | 2.07564920 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.06360977 |
| 18 | MP0003866_abnormal_defecation | 2.02363419 |
| 19 | MP0005409_darkened_coat_color | 2.02186057 |
| 20 | MP0005332_abnormal_amino_acid | 1.93866030 |
| 21 | MP0009643_abnormal_urine_homeostasis | 1.83959929 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 1.61768645 |
| 23 | MP0004858_abnormal_nervous_system | 1.60426948 |
| 24 | MP0000477_abnormal_intestine_morphology | 1.58532036 |
| 25 | MP0003868_abnormal_feces_composition | 1.56237230 |
| 26 | MP0005166_decreased_susceptibility_to | 1.53470645 |
| 27 | MP0001873_stomach_inflammation | 1.51274116 |
| 28 | MP0003718_maternal_effect | 1.46846327 |
| 29 | MP0001764_abnormal_homeostasis | 1.45877067 |
| 30 | MP0003252_abnormal_bile_duct | 1.41735068 |
| 31 | MP0000538_abnormal_urinary_bladder | 1.41064148 |
| 32 | MP0000678_abnormal_parathyroid_gland | 1.38696461 |
| 33 | MP0001765_abnormal_ion_homeostasis | 1.37879382 |
| 34 | MP0001188_hyperpigmentation | 1.36563324 |
| 35 | MP0005451_abnormal_body_composition | 1.30983148 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.29847333 |
| 37 | MP0004782_abnormal_surfactant_physiolog | 1.28657178 |
| 38 | MP0005670_abnormal_white_adipose | 1.28167376 |
| 39 | MP0001663_abnormal_digestive_system | 1.27279895 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 1.25674250 |
| 41 | MP0002136_abnormal_kidney_physiology | 1.22656689 |
| 42 | MP0003879_abnormal_hair_cell | 1.21405506 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 1.17536367 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.11727254 |
| 45 | MP0002796_impaired_skin_barrier | 1.11146306 |
| 46 | MP0000462_abnormal_digestive_system | 1.08728041 |
| 47 | MP0005381_digestive/alimentary_phenotyp | 1.05438335 |
| 48 | MP0000609_abnormal_liver_physiology | 1.02349469 |
| 49 | MP0000537_abnormal_urethra_morphology | 0.99436573 |
| 50 | MP0005448_abnormal_energy_balance | 0.98956346 |
| 51 | MP0002971_abnormal_brown_adipose | 0.91554956 |
| 52 | MP0004270_analgesia | 0.91498791 |
| 53 | MP0001845_abnormal_inflammatory_respons | 0.91021577 |
| 54 | MP0001756_abnormal_urination | 0.89143231 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 0.87794326 |
| 56 | MP0005535_abnormal_body_temperature | 0.86947624 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 0.84668026 |
| 58 | MP0002166_altered_tumor_susceptibility | 0.83107658 |
| 59 | MP0002822_catalepsy | 0.81306723 |
| 60 | MP0005501_abnormal_skin_physiology | 0.81273692 |
| 61 | MP0002098_abnormal_vibrissa_morphology | 0.80946281 |
| 62 | MP0004043_abnormal_pH_regulation | 0.79699103 |
| 63 | MP0001501_abnormal_sleep_pattern | 0.79529312 |
| 64 | MP0005666_abnormal_adipose_tissue | 0.75324650 |
| 65 | MP0000013_abnormal_adipose_tissue | 0.74999994 |
| 66 | MP0000230_abnormal_systemic_arterial | 0.74826675 |
| 67 | MP0008469_abnormal_protein_level | 0.74578253 |
| 68 | MP0009115_abnormal_fat_cell | 0.74405567 |
| 69 | MP0009642_abnormal_blood_homeostasis | 0.70588921 |
| 70 | MP0009785_altered_susceptibility_to | 0.69370402 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 0.69162115 |
| 72 | MP0005165_increased_susceptibility_to | 0.65593841 |
| 73 | MP0005083_abnormal_biliary_tract | 0.65435216 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 0.64229675 |
| 75 | MP0002396_abnormal_hematopoietic_system | 0.61662176 |
| 76 | MP0003724_increased_susceptibility_to | 0.61583296 |
| 77 | MP0003693_abnormal_embryo_hatching | 0.60565188 |
| 78 | MP0002006_tumorigenesis | 0.59129301 |
| 79 | MP0000249_abnormal_blood_vessel | 0.59071665 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 0.58317406 |
| 81 | MP0005025_abnormal_response_to | 0.57907327 |
| 82 | MP0002138_abnormal_hepatobiliary_system | 0.57604270 |
| 83 | MP0005058_abnormal_lysosome_morphology | 0.57417647 |
| 84 | MP0003436_decreased_susceptibility_to | 0.57085235 |
| 85 | MP0001881_abnormal_mammary_gland | 0.56739455 |
| 86 | MP0008872_abnormal_physiological_respon | 0.56611526 |
| 87 | MP0005334_abnormal_fat_pad | 0.56429636 |
| 88 | MP0002896_abnormal_bone_mineralization | 0.55515952 |
| 89 | MP0001835_abnormal_antigen_presentation | 0.53882136 |
| 90 | MP0006138_congestive_heart_failure | 0.52376040 |
| 91 | MP0009764_decreased_sensitivity_to | 0.51891427 |
| 92 | MP0003329_amyloid_beta_deposits | 0.49151611 |
| 93 | MP0001485_abnormal_pinna_reflex | 0.48959212 |
| 94 | MP0000604_amyloidosis | 0.48794748 |
| 95 | MP0003303_peritoneal_inflammation | 0.48702281 |
| 96 | MP0004947_skin_inflammation | 0.48496895 |
| 97 | MP0003953_abnormal_hormone_level | 0.48102352 |
| 98 | MP0006082_CNS_inflammation | 0.47584225 |
| 99 | MP0001790_abnormal_immune_system | 0.46618177 |
| 100 | MP0005387_immune_system_phenotype | 0.46618177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Malnutrition (HP:0004395) | 7.59770192 |
| 2 | Hydroxyprolinuria (HP:0003080) | 6.47976786 |
| 3 | Abnormality of proline metabolism (HP:0010907) | 6.47976786 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.91057482 |
| 5 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.87628003 |
| 6 | Chronic diarrhea (HP:0002028) | 4.82328806 |
| 7 | Abnormality of vitamin B metabolism (HP:0004340) | 4.54643263 |
| 8 | Ileus (HP:0002595) | 4.54220201 |
| 9 | Fat malabsorption (HP:0002630) | 4.39979242 |
| 10 | Confusion (HP:0001289) | 4.17466678 |
| 11 | Widely patent fontanelles and sutures (HP:0004492) | 4.11895420 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.11219805 |
| 13 | Acanthocytosis (HP:0001927) | 4.10220196 |
| 14 | Nausea (HP:0002018) | 4.02682210 |
| 15 | Alkalosis (HP:0001948) | 4.02386004 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.67936994 |
| 17 | Abnormality of vitamin metabolism (HP:0100508) | 3.62649797 |
| 18 | Abnormality of urine glucose concentration (HP:0011016) | 3.62017126 |
| 19 | Glycosuria (HP:0003076) | 3.62017126 |
| 20 | Proximal tubulopathy (HP:0000114) | 3.60860274 |
| 21 | Hyperactive renin-angiotensin system (HP:0000841) | 3.59888548 |
| 22 | Pigmentary retinal degeneration (HP:0001146) | 3.51573960 |
| 23 | Hyperglycinuria (HP:0003108) | 3.47622187 |
| 24 | Thin bony cortex (HP:0002753) | 3.39659160 |
| 25 | Metabolic alkalosis (HP:0200114) | 3.39445196 |
| 26 | Decreased circulating renin level (HP:0003351) | 3.36277754 |
| 27 | Hyperammonemia (HP:0001987) | 3.16826763 |
| 28 | Wide cranial sutures (HP:0010537) | 3.15678153 |
| 29 | Abdominal distention (HP:0003270) | 3.09949080 |
| 30 | Congenital sensorineural hearing impairment (HP:0008527) | 3.07584745 |
| 31 | Nephrolithiasis (HP:0000787) | 3.05394992 |
| 32 | Abnormality of renin-angiotensin system (HP:0000847) | 3.04292946 |
| 33 | Hyperuricemia (HP:0002149) | 3.03985850 |
| 34 | Increased purine levels (HP:0004368) | 3.03985850 |
| 35 | Hypolipoproteinemia (HP:0010981) | 3.02316587 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.00538513 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 3.00538513 |
| 38 | Xanthomatosis (HP:0000991) | 2.91627391 |
| 39 | Posterior subcapsular cataract (HP:0007787) | 2.88409829 |
| 40 | Megaloblastic anemia (HP:0001889) | 2.87854561 |
| 41 | Hypophosphatemia (HP:0002148) | 2.84735235 |
| 42 | Steatorrhea (HP:0002570) | 2.78998337 |
| 43 | Abnormal urine phosphate concentration (HP:0012599) | 2.72542492 |
| 44 | Hyperparathyroidism (HP:0000843) | 2.67573637 |
| 45 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.66100386 |
| 46 | Villous atrophy (HP:0011473) | 2.63602376 |
| 47 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.63602376 |
| 48 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.61323774 |
| 49 | Eczematoid dermatitis (HP:0000976) | 2.60593512 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.58494049 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.57197092 |
| 52 | Hyperphosphaturia (HP:0003109) | 2.48234469 |
| 53 | Hemorrhage of the eye (HP:0011885) | 2.40444505 |
| 54 | Focal segmental glomerulosclerosis (HP:0000097) | 2.40021081 |
| 55 | Metabolic acidosis (HP:0001942) | 2.36338713 |
| 56 | Hypotension (HP:0002615) | 2.32789544 |
| 57 | Facial shape deformation (HP:0011334) | 2.32729602 |
| 58 | Potter facies (HP:0002009) | 2.32729602 |
| 59 | Right ventricular cardiomyopathy (HP:0011663) | 2.31788492 |
| 60 | Renal tubular acidosis (HP:0001947) | 2.31735147 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.30016486 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.30016486 |
| 63 | Delayed epiphyseal ossification (HP:0002663) | 2.28680725 |
| 64 | Abnormality of magnesium homeostasis (HP:0004921) | 2.27568218 |
| 65 | Enlarged epiphyses (HP:0010580) | 2.25414945 |
| 66 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.22666768 |
| 67 | Abnormality of the costochondral junction (HP:0000919) | 2.21257610 |
| 68 | Subcapsular cataract (HP:0000523) | 2.20097923 |
| 69 | Cerebral palsy (HP:0100021) | 2.17842063 |
| 70 | Gout (HP:0001997) | 2.17369315 |
| 71 | Flat acetabular roof (HP:0003180) | 2.16174117 |
| 72 | Abnormal glucose tolerance (HP:0001952) | 2.08131067 |
| 73 | Hyperphosphatemia (HP:0002905) | 2.06004221 |
| 74 | Glomerulonephritis (HP:0000099) | 2.05123577 |
| 75 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.03199795 |
| 76 | Irritability (HP:0000737) | 2.01293912 |
| 77 | Growth hormone excess (HP:0000845) | 2.01180603 |
| 78 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 10.6395916 |
| 79 | Renal tubular dysfunction (HP:0000124) | 1.99321678 |
| 80 | Pili torti (HP:0003777) | 1.99084601 |
| 81 | Abnormality of complement system (HP:0005339) | 1.97920104 |
| 82 | Epidermoid cyst (HP:0200040) | 1.97818645 |
| 83 | Pancreatitis (HP:0001733) | 1.97670015 |
| 84 | Hypoalbuminemia (HP:0003073) | 1.97136439 |
| 85 | Abnormal albumin level (HP:0012116) | 1.97136439 |
| 86 | Lethargy (HP:0001254) | 1.96255772 |
| 87 | Nephritis (HP:0000123) | 1.91214031 |
| 88 | Glomerulosclerosis (HP:0000096) | 1.88445854 |
| 89 | Protuberant abdomen (HP:0001538) | 1.87301994 |
| 90 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.87188358 |
| 91 | Gastrointestinal dysmotility (HP:0002579) | 1.86736299 |
| 92 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85192460 |
| 93 | Conjugated hyperbilirubinemia (HP:0002908) | 1.82516356 |
| 94 | Multiple lipomas (HP:0001012) | 1.81854140 |
| 95 | Macrocytic anemia (HP:0001972) | 1.80844633 |
| 96 | Vomiting (HP:0002013) | 1.80363521 |
| 97 | Complement deficiency (HP:0004431) | 1.77736330 |
| 98 | Dehydration (HP:0001944) | 1.75729418 |
| 99 | Abnormal hair laboratory examination (HP:0003328) | 1.75354828 |
| 100 | Intrahepatic cholestasis (HP:0001406) | 1.73796363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.53505240 |
| 2 | MST1R | 5.86503905 |
| 3 | ERN1 | 4.57102724 |
| 4 | PDK2 | 4.16530192 |
| 5 | EPHA2 | 3.39118426 |
| 6 | PRKG2 | 3.11014158 |
| 7 | RIPK1 | 3.10544711 |
| 8 | MAP3K10 | 2.78436881 |
| 9 | TESK2 | 2.44850470 |
| 10 | STK39 | 2.34697822 |
| 11 | MET | 2.26733018 |
| 12 | EPHB2 | 1.99929143 |
| 13 | OXSR1 | 1.90967484 |
| 14 | PTK6 | 1.67762776 |
| 15 | FGFR4 | 1.57614885 |
| 16 | MAP3K12 | 1.49405892 |
| 17 | MAP3K2 | 1.32828192 |
| 18 | TYK2 | 1.31503056 |
| 19 | PIK3CA | 1.28795410 |
| 20 | MAP2K2 | 1.26617457 |
| 21 | DDR2 | 1.22431648 |
| 22 | GRK6 | 1.21036585 |
| 23 | PRPF4B | 1.16348678 |
| 24 | STK24 | 1.15179818 |
| 25 | EPHA3 | 1.14686349 |
| 26 | LMTK2 | 1.09977091 |
| 27 | EPHB1 | 1.09775162 |
| 28 | MATK | 1.09092071 |
| 29 | MAP3K1 | 1.07522849 |
| 30 | PDPK1 | 1.06100330 |
| 31 | TESK1 | 0.99866062 |
| 32 | ABL2 | 0.96043548 |
| 33 | MST4 | 0.94849505 |
| 34 | MYLK | 0.91309436 |
| 35 | MAP4K1 | 0.88506788 |
| 36 | AKT3 | 0.82018397 |
| 37 | MAP3K11 | 0.80000773 |
| 38 | MAPK11 | 0.78313299 |
| 39 | TNIK | 0.78291284 |
| 40 | BMX | 0.71506918 |
| 41 | IRAK3 | 0.70499152 |
| 42 | PAK4 | 0.69099911 |
| 43 | PIM2 | 0.68714074 |
| 44 | ERBB2 | 0.68038910 |
| 45 | PBK | 0.65882187 |
| 46 | BMPR2 | 0.65255528 |
| 47 | RIPK4 | 0.65186131 |
| 48 | WNK4 | 0.64989059 |
| 49 | NEK6 | 0.64665679 |
| 50 | PDK1 | 0.64565853 |
| 51 | NME2 | 0.63974032 |
| 52 | EPHA4 | 0.62650662 |
| 53 | CDC42BPA | 0.62083987 |
| 54 | PIM1 | 0.60026298 |
| 55 | FGFR3 | 0.58620816 |
| 56 | TRIB3 | 0.56178033 |
| 57 | NLK | 0.55380463 |
| 58 | TAOK1 | 0.54206143 |
| 59 | PRKACG | 0.53600266 |
| 60 | MUSK | 0.51005213 |
| 61 | PRKCA | 0.49926054 |
| 62 | MAP2K6 | 0.48836371 |
| 63 | CDK19 | 0.47595806 |
| 64 | PTK2 | 0.47341932 |
| 65 | TBK1 | 0.46892125 |
| 66 | CAMK2D | 0.46140750 |
| 67 | PRKAA2 | 0.45462271 |
| 68 | IRAK1 | 0.44612139 |
| 69 | PRKCZ | 0.44269145 |
| 70 | FER | 0.42998990 |
| 71 | PRKCI | 0.41351591 |
| 72 | KSR2 | 0.39798944 |
| 73 | CAMK2G | 0.38921460 |
| 74 | MAP3K3 | 0.37302167 |
| 75 | SRC | 0.36343309 |
| 76 | DYRK1B | 0.35718517 |
| 77 | MAP3K8 | 0.35479750 |
| 78 | CDK6 | 0.33132875 |
| 79 | PDGFRA | 0.31918048 |
| 80 | SMG1 | 0.31254505 |
| 81 | PRKCD | 0.29361461 |
| 82 | NME1 | 0.29303680 |
| 83 | BRAF | 0.25944814 |
| 84 | NEK1 | 0.25653425 |
| 85 | GRK1 | 0.25370546 |
| 86 | YES1 | 0.25275154 |
| 87 | LRRK2 | 0.24737761 |
| 88 | CAMK2B | 0.23811791 |
| 89 | MELK | 0.22878025 |
| 90 | FYN | 0.22143721 |
| 91 | CSK | 0.21744661 |
| 92 | ICK | 0.21213346 |
| 93 | PIK3CG | 0.21017273 |
| 94 | RET | 0.20739905 |
| 95 | ILK | 0.20182708 |
| 96 | DMPK | 0.19817550 |
| 97 | ZAP70 | 0.19641484 |
| 98 | MAPKAPK2 | 0.17064192 |
| 99 | MAP2K1 | 0.16659678 |
| 100 | RPS6KA2 | 0.15614544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.37091577 |
| 2 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.58366752 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.52697078 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.70954192 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.92147016 |
| 6 | Mineral absorption_Homo sapiens_hsa04978 | 2.64598503 |
| 7 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.50986036 |
| 8 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.31107995 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.26245578 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.16883395 |
| 11 | Galactose metabolism_Homo sapiens_hsa00052 | 2.16097305 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16072712 |
| 13 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.15509446 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.13235656 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.12542013 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.93906931 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.91208859 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.90608735 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.81307370 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.77136021 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77042710 |
| 22 | Retinol metabolism_Homo sapiens_hsa00830 | 1.75934957 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.75474985 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69231596 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.68217588 |
| 26 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.67466249 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.62758517 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.60746254 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.60366121 |
| 30 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.39199171 |
| 31 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.37028192 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.35910127 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28940623 |
| 34 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.24801254 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.21977889 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.21547680 |
| 37 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.21439793 |
| 38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.21127713 |
| 39 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.10682667 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.01915720 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.00908269 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96367425 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90981725 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.90756726 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89365714 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78110184 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73607731 |
| 48 | Allograft rejection_Homo sapiens_hsa05330 | 0.72888896 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68168408 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66162076 |
| 51 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65377082 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65256625 |
| 53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64547285 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64054282 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63857461 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60054628 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.56252714 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54398526 |
| 59 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53414401 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53135651 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51038656 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50085568 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49549374 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.49354595 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44887291 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38974983 |
| 67 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37619068 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.33970830 |
| 69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32130088 |
| 70 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.30068092 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29640645 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29157066 |
| 73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.27186679 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26207016 |
| 75 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.25802051 |
| 76 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.25759419 |
| 77 | Renin secretion_Homo sapiens_hsa04924 | 0.24574923 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.24025025 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.22138170 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.18994328 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.17813828 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.17327076 |
| 83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.14750369 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.13740340 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12858273 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.11596023 |
| 87 | Tight junction_Homo sapiens_hsa04530 | 0.10000198 |
| 88 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.08863338 |
| 89 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.08757241 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.08328766 |
| 91 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.04507042 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.02847798 |
| 93 | Cocaine addiction_Homo sapiens_hsa05030 | 0.02472151 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.01184286 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | -0.0544270 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0544114 |
| 97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0465305 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | -0.0339094 |
| 99 | Propanoate metabolism_Homo sapiens_hsa00640 | -0.0331369 |
| 100 | Influenza A_Homo sapiens_hsa05164 | -0.0127710 |

